VolitionRx Ltd
VNRX
22 hedge funds and large institutions have $10.5M invested in VolitionRx Ltd in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
118% more capital invested
Capital invested by funds: $4.84M → $10.5M (+$5.7M)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0.47% more ownership
Funds ownership: 0.48% → 0.95% (+0.47%)
15% less funds holding
Funds holding: 26 → 22 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$5.79M |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$422K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$36.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$31.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$96.5K |
| 2 |
Morgan Stanley
New York
|
-$55.5K |
| 3 |
BlackRock
New York
|
-$45.6K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$9.37K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.99K |
VNRX Hedge Fund Activity: Q3 2024 in Review
22 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2024, worth a combined $10.5M — up 118% from $4.84M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VNRX and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $5.79M. The largest seller was Bridgeway Capital Management, cutting an estimated $96.5K.
- 22 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2024, down from 26 in Q2 2024.
- Funds reported $10.5M of VolitionRx Ltd stock for Q3 2024, up 118% quarter-over-quarter.
- 3 funds opened new VolitionRx Ltd positions in Q3 2024 and 7 closed out, a net change of -4 holders.
- The largest VolitionRx Ltd buyer in Q3 2024 was Armistice Capital, an estimated $5.79M added.
- The largest VolitionRx Ltd seller in Q3 2024 was Bridgeway Capital Management, an estimated $96.5K sold.
Based on aggregated 13F filings for Q3 2024.